RecruitingNot Applicable

Early Diagnostic Response Model (EDRM)

United States300 participantsStarted 2022-06-16

Plain-language summary

Babies Can't Wait (BCW) in Georgia will be referring families with children seeking an autism spectrum disorder (autism) diagnosis at the Emory Autism Center's (EAC) Child Screening and Assessment Clinic.The objective of this study is to develop, pilot, and evaluate a diagnostic protocol for children identified at high risk for autism in the BCW early intervention program screening (part of a public health service). This program evaluation will be using pre- and post-data and data collected through the process to evaluate the effectiveness of the EDRM pilot.

Who can participate

Age range

16 Months – 36 Months

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All families of children between the ages of 16-30 months of age who scored ≥8 on the MCHAT-R and whose BCW provider refers the child to our clinic by 33 months of age will be a possible participant. Evaluations will be done by 36 months of age. * Referring BCW provider must be one of the participating BCW health districts in this pilot study. * Parent/Guardian needs to have basic English proficiency * Parent/Guardian needs to have internet access * Child must have exposure to English either at home or in out-of-home care (e.g., childcare setting). * Documentation of M-CHAT-R High-Risk failed score (≥ 8) must be documented in referral. Exclusion Criteria: * Families making self-referrals to the EAC or referrals outside of the targeted BCW districts will be excluded from recruitment for this study. * Children above the age of 33 months at the time of the referral will be excluded as the current EDRM protocol has not been developed in this phase of piloting for individuals over this age. * Non-English speakers will be excluded from participation due to the current protocol not being applicable to their needs as well as a high correlation between verbal language abilities and social communication and social interaction (SCI) abilities as part of the DSM-5-TR autism criteria.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Number of participants referred to the Early Diagnostic Response Model (EDRM)

Timeframe: Until the end of the study (approximately one year)

Number of participants consented in the Early Diagnostic Response Model (EDRM) study

Timeframe: Monthly until until the end of the study (approximately one year)

Response rate in the Early Diagnostic Response Model (EDRM) study

Timeframe: Until end of the study (approximately one year)

Number of participants that completed the Early Diagnostic Response Model (EDRM) study

Timeframe: Every 3 months (Quarterly) until end of study (approximately one year)

Time from referral to completion of the program

Timeframe: Up to 12 weeks post-intervention

Trial details

NCT IDNCT05419895

SponsorEmory University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2028-07

Contact for this trial

Allison Schwartz, PhD

404.727.8350 allison.schwartz@emory.edu

View on ClinicalTrials.gov More Autism Spectrum Disorder trials